| # | Drug | Count |
|---|---|---|
| 0 | MELPHALAN HYDROCHLORIDE | 20 |
| 1 | ASPIRIN | 14 |
| 2 | ASPIRIN 325 MG | 14 |
| 3 | ASPIRIN 81 MG | 14 |
| 4 | CARBOPLATIN | 12 |
| 5 | AFLIBERCEPT | 8 |
| 6 | CEFTAZIDIME | 8 |
| 7 | CIPROFLOXACIN | 8 |
| 8 | CIPROFLOXACIN HYDROCHLORIDE | 8 |
| 9 | CIPROFLOXACIN TABLETS | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 1 | 0.0027 |
| 1 | SODIUM NITROPRUSSIDE | 1 | 0.0026 |
| 2 | NATAMYCIN | 1 | 0.0024 |
| 3 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 4 | TEBENTAFUSP | 1 | 0.0017 |
| 5 | FLUORESCEIN | 1 | 0.0016 |
| 6 | PEGCETACOPLAN | 3 | 0.0016 |
| 7 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | 1 | 0.0013 |
| 8 | CEFTAZIDIME | 8 | 0.0010 |
| 9 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 1 | Corticosteroid [EPC] | 16 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 15 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 15 |
| 4 | Platinum-based Drug [EPC] | 12 |
| 5 | Benzodiazepine [EPC] | 11 |
| 6 | Insulin Analog [EPC] | 11 |
| 7 | Glycopeptide Antibacterial [EPC] | 9 |
| 8 | Insulin [EPC] | 9 |
| 9 | Topoisomerase Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Polyene Antimicrobial [EPC] | 1 | 0.0024 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 2 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 3 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 4 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 6 | Hedgehog Pathway Inhibitor [EPC] | 3 | 0.0003 |
| 7 | Recombinant Human Nerve Growth Factor [EPC] | 4 | 0.0003 |
| 8 | Photoenhancer [EPC] | 1 | 0.0003 |
| 9 | Antiseptic [EPC] | 1 | 0.0002 |